Matthijs Moerland Selected Research

Omiganan

1/2022	Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
1/2020	Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthijs Moerland Research Topics

Disease

8	Atherosclerosis 10/2009 - 09/2006
5	Erythema 01/2022 - 11/2018
5	Inflammation (Inflammations) 01/2022 - 07/2008
3	Thrombosis (Thrombus) 12/2011 - 02/2003
2	Necrosis 01/2022 - 10/2013
2	Blister (Bulla) 01/2022 - 01/2022
2	Sleepiness 01/2021 - 08/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 10/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2016
2	Injection Site Reaction 01/2016 - 12/2015
2	Rupture 12/2011 - 03/2010
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 03/2010
1	Dysbiosis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Nasopharyngitis 01/2021
1	Phlebitis 01/2021
1	Headache (Headaches) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Cystinosis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Thrombophilia 08/2020
1	Hemorrhage 07/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Multiple Sclerosis 01/2020
1	Neoplasms (Cancer) 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Endotoxemia 01/2018
1	Stable Angina 04/2016
1	Idiopathic Pulmonary Fibrosis 03/2016
1	Fibrosis (Cirrhosis) 03/2016
1	Hematuria 10/2013

Drug/Important Bio-Agent (IBA)

5	Lipoproteins (Lipoprotein)IBA 12/2016 - 09/2006
4	Phospholipid Transfer ProteinsIBA 10/2009 - 09/2006
3	CytokinesIBA 01/2022 - 01/2020
3	LDL Receptors (LDL Receptor)IBA 07/2008 - 12/2007
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Antimicrobial PeptidesIBA 01/2022 - 01/2020
2	OmigananIBA 01/2022 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2021
2	Huntingtin ProteinIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	VaccinesIBA 10/2020 - 01/2020
2	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 11/2018
2	LipidsIBA 12/2016 - 09/2006
2	MDCO-216IBA 12/2016 - 04/2016
2	HDL LipoproteinsIBA 04/2016 - 09/2006
2	CholesterolIBA 04/2016 - 06/2009
2	OligonucleotidesIBA 01/2016 - 10/2013
2	CreatinineIBA 12/2015 - 10/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	InterleukinsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	SynucleinsIBA 01/2022
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Cysteamine (Mercaptamine)FDA Link 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Delayed-Action PreparationsIBA 01/2021
1	E-SelectinIBA 08/2020
1	Erythropoietin FDA Link 08/2020
1	SugammadexIBA 07/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	Pharmaceutical PreparationsIBA 11/2018
1	Messenger RNA (mRNA)IBA 11/2018
1	EndotoxinsIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2017
1	Apolipoproteins AIBA 12/2016
1	Sodium-Glucose Transport ProteinsIBA 11/2016
1	ISIS 388626IBA 11/2016
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2016
1	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2016
1	Apoprotein(a) (Apolipoprotein (a))IBA 04/2016
1	Amyloid (Amyloid Fibrils)IBA 03/2016
1	PRM-151IBA 03/2016
1	SPC5001IBA 12/2015
1	Antisense OligonucleotidesIBA 10/2013
1	N- (1- (3,4- difluorobenzyl)piperidin- 4- yl)- 6- (trifluoromethyl)pyridazin- 3- amineIBA 08/2012
1	Serotonin ReceptorsIBA 12/2011
1	Dopamine (Intropin)FDA LinkGeneric 03/2010
1	CollagenIBA 03/2010
1	Serotonin (5 Hydroxytryptamine)IBA 03/2010

Therapy/Procedure

6	Therapeutics 01/2021 - 10/2013
1	Topical Administration 01/2022
1	Catheters 01/2021
1	Lasers (Laser) 01/2020